Former President Joe Biden's office announced recently that he has been diagnosed with an "aggressive" form of prostate cancer, which has spread to his bones. Headlines have been chock full of questions about his diagnosis, treatment options and future health.
Prostate cancer is the second most common cancer among men in the United States, and can often be treated successfully, according to the American Cancer Society.
Prostate cancer is the second leading cause of cancer death for men in North Carolina, according to the UNC Chapel Hill Men’s Health Program.
Almost all those who are diagnosed early, before the cancer has spread, survive for five years and beyond — but that drops to only 34% after it has spread.
On the next Charlotte Talks, we look at the treatment, screening and testing options for prostate cancer patients. We also look at promising new treatment research recently released by Duke University and hear from a prostate cancer survivor.
GUESTS:
Dr. Andrew Armstrong, professor of Medicine at the Duke University School of Medicine, oncologist
Dr. Kathryn Hacker Gessner, assistant professor of urology at UNC
Bob Lane, Charlotte-suburb cancer survivor
